← Ticker index
DXCM
Ticker
DXCM
Congressional Trades
86
by 8 members
Ticker disclosure brief
Congressional disclosure records for DXCM
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Ro Khanna
SELL · 2026-06-30
Largest range
$250K – $500K
Tina Smith
Longest observed gap
46d
Jefferson Shreve
Highest 30d vs SPY
26.7%
Tina Smith
Purchase rows
36
42%
Sale rows
45
52%
Disclosed midpoint
$2.9M
range estimate
Unique Traders
8
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats45 · 52%
Republicans41 · 48%
Lobbying filings
all →- 2026-06-15$0DEXCOMProvide strategic counsel and advocate on issues related to Medicare coverage and regulatory policy.
- 2026-04-20$380KDEXCOM INC.CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking CGM Coverage policies Issues related to breakthrough technology Issues related to global supply chains Issues related to the Administration's Executive Orders
- 2026-04-20$50KDEXCOM INC.General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring
- 2026-04-20$40KDEXCOM INC.Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors.
- 2026-04-18$75KDEXCOMcontinuous glucose monitoring continuous glucose monitoring
- 2026-01-20$390KDEXCOM INC.Issues related to global supply chains Issues related to the Administration's Executive Orders CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking CGM Coverage policies Issues related to breakthrough technology
- 2026-01-20$50KDEXCOM INC.General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring
- 2026-01-20$40KDEXCOM INC.Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors.
- 2026-01-19$75KDEXCOMcontinuous glucose monitoring continuous glucose monitoring
- 2025-10-20$370KDEXCOM INC.CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology CGM Coverage policies Issues related to breakthrough technology Issues related to global supply chains Issues related to the Administration's Executive Orders
Loading trade analytics…
All Disclosed Trades
Page 3 · 25 of 86 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 42d | receipt → |
| 2025-05-08 | RJefferson Shreve | BUY | $15K – $50K | 46dApparent delay | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d | receipt → |
| 2025-05-08 | RJefferson Shreve | BUY | $15K – $50K | 45d | receipt → |
| 2025-05-08 | RJefferson Shreve | BUY | $15K – $50K | 45d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d | receipt → |
| 2025-05-15 | RRobert Bresnahan | BUY | $1K – $15K | 26d | receipt → |
| 2025-05-28 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2025-05-28 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2025-05-15 | RRobert Bresnahan | BUY | $1K – $15K | 25d | receipt → |
| 2025-05-15 | RRobert Bresnahan | BUY | $1K – $15K | 25d | receipt → |
| 2025-04-23 | DRo Khanna | SELL | $1K – $15K | 19d | receipt → |
| 2025-04-23 | DRo Khanna | SELL | $1K – $15K | 19d | receipt → |
| 2025-04-08 | RMichael McCaul | BUY | $50K – $100K | 34d | receipt → |
| 2025-04-07 | RJefferson Shreve | SELL | $15K – $50K | 31d | receipt → |
| 2025-04-07 | RJefferson Shreve | SELL | $15K – $50K | 31d | receipt → |
| 2025-04-08 | RRobert Bresnahan | SELL | $1K – $15K | 20d | receipt → |
| 2025-04-08 | RRobert Bresnahan | SELL | $1K – $15K | 20d | receipt → |
| 2025-02-25 | RRobert Bresnahan | BUY | $1K – $15K | 30d | receipt → |
| 2025-02-25 | RRobert Bresnahan | BUY | $1K – $15K | 30d | receipt → |
| 2024-12-31 | RKevin Hern | SELL | $50K – $100K | 15d | receipt → |
| 2024-12-31 | RKevin Hern | SELL | $50K – $100K | 15d | receipt → |
| 2024-12-31 | RKevin Hern | SELL | $50K – $100K | 2d | receipt → |
| 2024-11-12 | DRo Khanna | BUY | $1K – $15K | 23d | receipt → |
| 2024-11-12 | DRo Khanna | BUY | $1K – $15K | 23d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.